An association is urging the Latvian government to provide funding for diabetes care devices for adults, arguing it's more cost-effective than treating complications later.
A Latvian association is advocating for state funding to support adults with diabetes by providing continuous glucose monitoring sensors and insulin pumps, devices currently covered only for those under 18 and 24 years old respectively. Many diabetes patients believe that extending this support to adults would ultimately be less costly for the government compared to treating complications that arise from inadequate care.
Two men, Ivans Mirzojans and Kārlis Gailītis, are sharing their personal experiences with Type 1 diabetes, which they developed post-COVID-19. Mirzojans emphasizes that he contracted the virus while working in a COVID unit, leading to the onset of diabetic symptoms. They highlight the necessity for continuous monitoring and treatment capabilities beyond the current age limits set by the health ministry, as diabetes is a chronic condition lasting a lifetime.
The Latvian Health Ministry has responded by stating that there are budget constraints, stating that funding needs to be approached gradually. This ongoing debate presents significant implications for health policy, as patients contend that addressing diabetes more comprehensively from an earlier age could prevent future health crises and associated costs for the healthcare system.
